Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...

More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...

Oncology, titled "Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention," a research team from Guangzhou ...

and therapies that may help to reactivate its effect. There are two types of genes that are important in the development and growth of cancers: oncogenes and tumor-suppressor genes. Most often ...

Can tumor suppressor genes and proto-oncogenes ... Today’s War on Cancer: Using Genes to Tailor Therapy Cancer progression involves a complex series of genetic changes that occur over time.

"For cancer, mutations in tumor suppressor genes, drug resistance ... in this study involving mice could eventually lead to novel therapies for treating cancer and cardiovascular diseases through ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

A new review published in Genes & Diseases explores the pivotal role of the ubiquitin-proteasome system (UPS) in regulating the tumor microenvironment (TME) and driving cancer progression. The study ...

The data, published in eLife, showcase the potential of NPRL2 as a single-agent therapy using the Oncoprex Delivery System. The Oncoprex system delivered the NPRL2 tumor suppressor gene via lipid ...

Signs an Amended & Restated License Agreement for Multiple Technologies for Gene Therapy for Type 1 and Type 2 Diabetes Forms a Wholl ...